Sharp Therapeutics Corp (SHRX)

Currency in CAD
0.50
0.00(0.00%)
Closed·

SHRX Financial Summary

Key Ratios

P/E Ratio-1.1
Price/Book-15.49
Debt / Equity-197.34%
Return on Equity87.03%
Dividend Yield0.00%
EBITDA-2.52M
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2022
31/12
2023
31/12
2024
31/12
* In Millions of USD (except for per share items)

Earnings

Latest Release
May 22, 2025
EPS / Forecast
-0.12 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

FAQ

What was Sharp Therapeutics's net income for the latest quarter?

Sharp Therapeutics's net income for the latest quarter was -3.25.

How does Sharp Therapeutics's debt to equity ratio compare to industry standards?

Sharp Therapeutics's total debt-to-equity ratio is -197.34%.

What is Sharp Therapeutics's return on investment on a TTM basis?

Sharp Therapeutics's trailing twelve months (TTM) return on investment (ROI) is 87.03%.

Did Sharp Therapeutics gain or lose cash last quarter?

In the latest quarter, Sharp Therapeutics's net change in cash was -1.47 million.

What were Sharp Therapeutics's total assets and liabilities in the latest quarter?

As of the latest quarter, Sharp Therapeutics reported total assets of 3.16 million and total liabilities of 2.55 million.

What was Sharp Therapeutics's revenue per share for the latest quarter?

Sharp Therapeutics's revenue per share for the latest quarter was 0.08.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.